You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Small Molecule Targeted Cancer Therapy Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market
The research report studies the Small Molecule Targeted Cancer Therapy market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Small Molecule Targeted Cancer Therapy Scope and Segment
The global Small Molecule Targeted Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targeted Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
by Application, this report covers the following segments
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers
Global Small Molecule Targeted Cancer Therapy market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Small Molecule Targeted Cancer Therapy key players in this market include:
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
1 Market Overview of Small Molecule Targeted Cancer Therapy
1.1 Small Molecule Targeted Cancer Therapy Market Overview
1.1.1 Small Molecule Targeted Cancer Therapy Product Scope
1.1.2 Small Molecule Targeted Cancer Therapy Market Status and Outlook
1.2 Global Small Molecule Targeted Cancer Therapy Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Small Molecule Targeted Cancer Therapy Market Size by Region (2016-2027)
1.4 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2016-2021)
1.5 Global Small Molecule Targeted Cancer Therapy Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
1.6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
1.6.2 Europe Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
1.6.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
1.6.4 Latin America Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
1.6.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2016-2027)
2 Small Molecule Targeted Cancer Therapy Market Overview by Type
2.1 Global Small Molecule Targeted Cancer Therapy Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2016-2021)
2.3 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2022-2027)
2.4 Monoclonal Antibodies
2.5 Small Molecules
2.6 Small Molecule Drug Conjugates
3 Small Molecule Targeted Cancer Therapy Market Overview by Application
3.1 Global Small Molecule Targeted Cancer Therapy Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2016-2021)
3.3 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2022-2027)
3.4 Lymphoma
3.5 Melanoma
3.6 Multiple Myeloma
3.7 Breast Cancer
3.8 Prostate Cancer
3.9 Other Cancers
4 Small Molecule Targeted Cancer Therapy Competition Analysis by Players
4.1 Global Small Molecule Targeted Cancer Therapy Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2020)
4.3 Date of Key Players Enter into Small Molecule Targeted Cancer Therapy Market
4.4 Global Top Players Small Molecule Targeted Cancer Therapy Headquarters and Area Served
4.5 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Small Molecule Targeted Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 OncoGenex Pharmaceuticals Inc.
5.1.1 OncoGenex Pharmaceuticals Inc. Profile
5.1.2 OncoGenex Pharmaceuticals Inc. Main Business
5.1.3 OncoGenex Pharmaceuticals Inc. Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.1.4 OncoGenex Pharmaceuticals Inc. Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.1.5 OncoGenex Pharmaceuticals Inc. Recent Developments
5.2 Cytokinetics Inc.
5.2.1 Cytokinetics Inc. Profile
5.2.2 Cytokinetics Inc. Main Business
5.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.2.4 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.2.5 Cytokinetics Inc. Recent Developments
5.3 Hospira Inc.
5.3.1 Hospira Inc. Profile
5.3.2 Hospira Inc. Main Business
5.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.3.4 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.3.5 GlaxoSmithKline plc Recent Developments
5.4 GlaxoSmithKline plc
5.4.1 GlaxoSmithKline plc Profile
5.4.2 GlaxoSmithKline plc Main Business
5.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.4.4 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.4.5 GlaxoSmithKline plc Recent Developments
5.5 Boehringer Ingelheim GmbH
5.5.1 Boehringer Ingelheim GmbH Profile
5.5.2 Boehringer Ingelheim GmbH Main Business
5.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.5.4 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.5.5 Boehringer Ingelheim GmbH Recent Developments
5.6 Bayer HealthCare AG
5.6.1 Bayer HealthCare AG Profile
5.6.2 Bayer HealthCare AG Main Business
5.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.6.4 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.6.5 Bayer HealthCare AG Recent Developments
5.7 Abbott Laboratories
5.7.1 Abbott Laboratories Profile
5.7.2 Abbott Laboratories Main Business
5.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.7.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2016-2021)
5.7.5 Abbott Laboratories Recent Developments
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Small Molecule Targeted Cancer Therapy Market Dynamics
11.1 Small Molecule Targeted Cancer Therapy Industry Trends
11.2 Small Molecule Targeted Cancer Therapy Market Drivers
11.3 Small Molecule Targeted Cancer Therapy Market Challenges
11.4 Small Molecule Targeted Cancer Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Au
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125